Jazz Pharmaceuticals plc

符号: JAZZ

NASDAQ

124.79

USD

今天的市场价格

16.5122
市盈率
0.0368
PEG比率
7.78B
MRK市值
0.00%
DIV收益率

Jazz Pharmaceuticals plc (JAZZ) 财务报表

Q: 什么是 Jazz Pharmaceuticals plc (JAZZ) 总资产是多少？

Jazz Pharmaceuticals plc (JAZZ) 总资产为 .

Download

年度季度

线性对数

在图表中，您可以看到的动态默认数字 Jazz Pharmaceuticals plc (JAZZ). 的默认数据。公司收入显示 1242.022 M 的平均值，即 0.320 % 增长率。整个期间的平均毛利润为 1086.479 M，即 0.332 %. 平均毛利率为 0.839 %. 公司去年的净收入增长率为 -2.937 %，等于 0.694 % % 整个公司历史的平均增长率.,

年度季度

10Y 20Y 30Y 40Y

资产负债表

深入分析 Jazz Pharmaceuticals plc 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为，反映了公司的高点和低点。与季度相比，这一数字调整为0. 回顾过去一年，总资产变化为 0.052. 在流动资产领域，JAZZ 的报告货币为3263.921. 这些资产中的很大一部分，即 1626.31 是现金和短期投资。与去年的数据相比，该部分的变化率为0.845%. 公司的长期投资虽然不是其重点，但以报告货币计算的4.7（如果有的话）为4.7。这表明与上一报告期相比，-14.545% 的差异反映了公司的战略转变. 公司的债务概况显示，以报告货币计算的长期债务总额为 5107.988. 这一数字表明，0.000% 的年同比变化. 股东权益总额所体现的股东价值是以报告货币计算的 3736.997. 这方面的年同比变化率为 0.211%. 深入了解公司财务信息后，会发现更多细节。应收账款净额的估值为705.794，存货估值为 597.04，商誉估值为 1753.13（如有. 无形资产总额（如果有）按 5418.04 估值. 应付账款和短期债务分别为 102.75 和 624.4. 债务总额为5796.65，债务净额为 4590.34. 其他流动负债为 774.47，加上总负债 7656.36. 最后，如果存在推荐股票，则其估值为 0.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006
balance-sheet.row.cash-and-short-term-investments	5742.22	1626.3	881.5	591.4	2132.8	1077.3	824.6	601	426	988.8	684	636.5	387.2	157.9	44.8	15.6	25.9	102.9	78.9	20.6
balance-sheet.row.short-term-investments	930	420	30	0	1075	440	515	215	60	0	0	0	0	75.8	0	0	1	12	0	0
balance-sheet.row.net-receivables	2567.96	705.8	651.5	563.4	396.5	356	263.8	224.1	234.2	209.7	186.4	124.8	75.5	34.4	22.1	12.3	6.6	5.4	5.4	3.6
balance-sheet.row.inventory	2540.86	597	714.1	1072.7	95.4	78.6	53	43.2	34.1	19.5	30	28.7	26.5	3.9	5	3.4	4.8	2.2	3	3.3
balance-sheet.row.other-current-assets	754.22	334.8	267.2	252.4	152.5	78.9	67.6	76.7	29.3	19	21.3	33.8	19.1	1.3	0.3	1	2.4	0.4	0.5	0.4
balance-sheet.row.total-current-assets	12304.18	3263.9	2606.1	2611.3	2839.6	1630.3	1234	968.3	748.1	1257.7	1015.8	864.6	551.6	199.1	74.5	37	44	116.1	91.6	31.4
balance-sheet.row.property-plant-equipment-net	1123.89	235	301.4	343.4	257.1	270.9	200.4	170.1	107.5	85.6	58.4	14.2	7.3	1.6	0.7	1.1	2.5	3.9	2.1	1.9
balance-sheet.row.goodwill	6924.57	1753.1	1692.7	1827.6	958.3	920	927.6	947.5	893.8	657.1	702.7	450.5	442.6	38.2	38.2	38.2	38.2	38.2	38.2	38.9
balance-sheet.row.intangible-assets	22305.88	5418	5794.4	7152.3	2195.1	2441	2731.3	2979.1	3012	1185.6	1437.4	812.4	870	14.6	22	29.9	32.5	36	69.1	78.7
balance-sheet.row.goodwill-and-intangible-assets	29230.45	7171.2	7487.1	8979.9	3153.4	3361	3659	3926.7	3905.8	1842.7	2140.1	1262.9	1312.6	52.8	60.2	68.1	70.7	74.3	107.4	117.6
balance-sheet.row.long-term-investments	25.24	4.7	5.5	12	5.2	7.4	9.6	7.7	9.7	23.3	33.2	14.6	16.6	0	0	0	0	0	0	0
balance-sheet.row.tax-assets	1771.38	477.8	376.2	311.1	254.9	221.4	57.9	34.6	15.1	122.9	75.5	74.6	74.8	0	0	0	0	0	0	0
balance-sheet.row.other-non-current-assets	449.94	240.7	58.9	40.8	25.7	47.9	42.7	16.4	14.1	27.5	15.9	7.3	3.7	0.1	0.3	1.2	0.2	13.3	13.5	13.8
balance-sheet.row.total-non-current-assets	32600.91	8129.4	8229.1	9687.3	3696.3	3908.6	3969.5	4155.4	4052.2	2102	2323.1	1373.6	1414.9	54.4	61.3	70.4	73.5	91.5	123	133.4
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	44905.09	11393.4	10835.3	12298.6	6535.9	5538.9	5203.5	5123.7	4800.2	3359.7	3339	2238.2	1966.5	253.6	135.7	107.4	117.5	207.6	214.6	164.8
balance-sheet.row.account-payables	436.48	102.8	90.8	100.3	26.9	47.5	40.6	24.4	22.4	21.8	25.1	21	15.9	5.1	3	2.2	5.7	2.9	5.4	4.8
balance-sheet.row.short-term-debt	1324.61	624.4	31	31	246.3	33.4	33.4	40.6	36.1	37.6	9.4	5.6	29.7	39.3	23.4	33.2	122.4	3.5	2.2	0
balance-sheet.row.tax-payables	231.72	35.1	7.7	9.6	25.2	11	1.2	21.6	4.5	1.8	7.6	0.3	39.9	0	0	0	0	0	0	0
balance-sheet.row.long-term-debt-total	21794.59	5108	5765.2	6106.1	1988.6	1725.1	1563	1540.4	1993.5	1166.9	1333	544.4	427.1	0	24.6	91.1	0	75.1	74.3	73.6
Deferred Revenue Non Current	64.26	64.3	0	0.5	2.3	4.9	9.6	16.1	2.6	3.7	4.5	5.7	6.8	7.9	9.1	10.2	11.3	12.5	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	3531.91	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	3168.01	774.5	811	675.9	377.9	278.8	266.1	220.4	197.8	165.9	181.1	176.3	144.8	7.3	32.2	21.3	33	29	21.5	18.6
balance-sheet.row.total-non-current-liabilities	25853.81	6119.7	6816.3	7524.1	2222.4	2063.4	2100.6	2116.6	2665.5	1534.4	1750.9	738.7	653.7	7.9	45.2	121	36.9	115.7	360.3	259.7
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	297.5	64.3	71.8	87.2	140	151.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	30818	7656.4	7749.5	8333.4	2876.2	2427.9	2446.1	2410.6	2922.9	1761	1967.7	942.7	845.2	60.8	105.2	180.2	210.4	152.6	390.9	283
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	207.6	0	0
balance-sheet.row.common-stock	0.24	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0
balance-sheet.row.retained-earnings	3377.81	878.7	733.6	830.2	1159.9	1067.8	841	918	528.9	302.7	34.7	18.5	-61.3	-349.9	-474.9	-507.6	-500.8	-316.5	-177.6	-118.3
balance-sheet.row.accumulated-other-comprehensive-income-loss	-3724.13	-841.7	-1125.5	-400.4	-134.4	-223.4	-197.8	-140.9	-317.3	-267.5	-122.1	56.2	31	0	-6.2	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	14433.16	3700	3477.6	3535.3	2634.1	2266.5	2114.1	1936	1665.7	1563.4	1458.5	1220.8	1151.5	542.7	511.6	434.8	407.9	163.9	1.3	0
balance-sheet.row.total-stockholders-equity	14087.09	3737	3085.7	3965.2	3659.7	3111	2757.4	2713.1	1877.3	1598.6	1371.1	1295.5	1121.3	192.8	30.6	-72.8	-92.9	55	-176.3	-118.2
balance-sheet.row.total-liabilities-and-stockholders-equity	44905.09	11393.4	10835.3	12298.6	6535.9	5538.9	5203.5	5123.7	4800.2	3359.7	3339	2238.2	1966.5	253.6	135.7	107.4	117.5	207.6	214.6	164.8
balance-sheet.row.minority-interest	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-equity	14087.09	3737	3085.7	3965.2	3659.7	3111	2757.4	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	44905.09	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	940.2	424.7	35.5	12	1075	440	515	215	60	23.3	33.2	14.6	16.6	75.8	0	0	1	12	0	0
balance-sheet.row.total-debt	23183.46	5796.7	5796.2	6137.1	2234.9	1758.5	1596.4	1581	2029.6	1204.5	1342.4	550	456.8	0	48	124.3	122.4	78.6	76.5	73.6
balance-sheet.row.net-debt	18191.25	4590.3	4914.7	5545.7	1177.1	1121.1	1286.8	1195	1663.7	215.7	658.4	-86.5	69.6	-82.1	3.2	108.7	97.5	-24.4	-2.5	53

现金流量表

在 Jazz Pharmaceuticals plc 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 0.380 的转变。该公司最近通过发行 46.46 扩大了股本，与上一年相比出现了0.000 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到-163062000.000. 与上一年相比， -0.635 发生了变化. 在同一时期，公司记录了 638.7, -19 和 -31，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为0.000，同比差异为0.000. 此外，公司还将0 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 -50.95，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006
cash-flows.row.net-income	414.83	414.8	-224.1	-329.7	238.6	523.4	447.1	487.8	396.8	329.5	57.3	216.3	288.6	125	32.8	-6.8	-184.3	-138.8	-59.4	-85.2
cash-flows.row.depreciation-and-amortization	638.7	638.7	629.5	552.5	278.3	370.2	216.7	165.2	113.8	108.1	133.7	82.1	74.2	7.8	8.7	9.1	15	10.5	10.3	5.4
cash-flows.row.deferred-income-tax	-260.22	-260.2	-292.3	69.2	-136.9	-236.6	-88.8	-225.6	-41.2	-61.2	-43.4	-10.1	-113.9	-123.7	12.6	0	26.8	-11.9	0	0
cash-flows.row.stock-based-compensation	226.84	226.8	222	189	121	110.6	102.4	106.9	98.8	91.5	69.6	44.6	23	20.7	8.2	6	8.1	6.1	0	0
cash-flows.row.change-in-working-capital	-204.44	-204.4	9.9	-48	-85.4	-150.1	23.3	26.8	-22.7	-6.1	-51.4	-81	-5.2	-3.6	-5.8	-24.1	2.1	27.5	15.4	2.8
cash-flows.row.account-receivables	-51.88	-51.9	-90.1	-92.7	-38.6	-92.3	-40.1	12.3	-25.6	-24.8	-55	-48.8	-4.7	-12.3	-9.8	-5.7	-1.3	-0.3	0	0
cash-flows.row.inventory	-13.42	-13.4	-49.6	-48.9	-30.5	-32.8	-18.5	-8.7	-17	6.3	-7.6	-8.5	1.7	1.3	-1.6	0.9	-2.6	0.5	-0.5	-0.2
cash-flows.row.account-payables	9.6	9.6	-11.2	57	-18.9	4.8	17	0.2	0.4	-2.3	-38	5.1	-7.3	2.1	0.9	-3.6	2.9	-2.6	0	0
cash-flows.row.other-working-capital	-148.74	-148.7	160.9	36.6	2.7	-29.7	64.9	22.9	19.5	14.7	49.2	-28.7	5.2	5.3	4.7	-15.7	3.1	29.9	15.9	3.1
cash-flows.row.other-non-cash-items	276.29	276.3	926.9	345.4	484.2	159	98.2	132	45	70.1	240	31.7	-17.1	125.4	2.4	0	2.1	25.6	-23.7	24.7
cash-flows.row.net-cash-provided-by-operating-activities	1092.01	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-24.96	-24	-498.2	-45.5	-379.3	-182.3	-131.5	-114	-181.6	-36	-239	-11.3	-22.5	-5.8	-4.7	-6.1	-28.7	-3.1	-1.7	-1.4
cash-flows.row.acquisitions-net	-20	0	53	-6234.8	-364.3	-142.2	111.1	85	-1502.4	33.7	-828.7	0	-448.6	-4.5	0	0	0	10.2	0.1	-146.1
cash-flows.row.purchases-of-investments	-390.1	-390.1	-61	-26.8	-2397.7	-917.1	-1165.9	-385	-65.3	0	0	0	-37.4	-79.9	0	0	0	-10.8	-1.7	0
cash-flows.row.sales-maturities-of-investments	270	270	60	1095	1755	985	855	230	173.8	0	0	0	113.2	4	2.6	1	3.4	10.8	1.7	6
cash-flows.row.other-investing-activites	2	-19	0	0	378.5	101.3	-63.2	-85	-173.8	0	0	0	0	4.9	0	-1.1	13.4	-1.7	0	-12.2
cash-flows.row.net-cash-used-for-investing-activites	-163.06	-163.1	-446.2	-5212.1	-1007.7	-155.3	-394.5	-268.9	-1749.3	-2.3	-1067.6	-11.3	-395.3	-81.2	-2.1	-6.1	-11.9	5.3	-1.5	-153.8
cash-flows.row.debt-repayment	-31	-31	-582	-1320.6	-889.6	-33.4	-25.7	-886.1	-178.3	-1065.8	-309.5	-465.9	-11.9	-49.5	-136.3	0	-0.5	0	0	0
cash-flows.row.common-stock-issued	46.46	46.5	98	135.3	99.7	57.8	0	0	0	0	0	0	0	0	56.8	6.8	24.5	98.5	100	177.9
cash-flows.row.common-stock-repurchased	-313.03	-269.8	-0.1	-35.6	-146.5	-301.4	-523.7	-98.8	-278.3	-61.6	-42.2	-136.5	0	0	0	6.4	6.4	0	0	0
cash-flows.row.dividends-paid	-112.28	0	-98	-99.7	-99.7	-57.8	0	0	0	0	0	0	0	0	0	0	-6.4	0	0	0
cash-flows.row.other-financing-activites	104.59	-51	52.6	5291.1	1564.2	41.1	70.3	575.8	997.6	913	1064.6	578.4	460.4	16.4	52	-0.5	40.1	1.3	17.2	15
cash-flows.row.net-cash-used-provided-by-financing-activities	-305.25	-305.3	-529.5	3970.5	528.1	-293.7	-479.1	-409.1	541	-214.3	712.9	-24	448.5	-33.1	-27.5	12.7	64.1	99.8	117.2	192.9
cash-flows.row.effect-of-forex-changes-on-cash	1.14	1.1	-6.2	-3.2	0.4	0.4	-1.7	5	-5	-10.6	-3.5	1	2.1	0	0	0	0	0	0	0
cash-flows.row.net-change-in-cash	634.83	354.8	290	-466.3	420.4	327.7	-76.4	20.1	-622.8	304.7	47.5	249.3	305.1	37.3	29.2	-9.3	-78	24	58.3	-13.1
cash-flows.row.cash-at-end-of-period	4992.22	1206.3	881.5	591.4	1057.8	637.3	309.6	386	366	988.8	684	636.5	387.2	82.1	44.8	15.6	24.9	102.9	78.9	20.6
cash-flows.row.cash-at-beginning-of-period	4357.39	851.5	591.4	1057.8	637.3	309.6	386	366	988.8	684	636.5	387.2	82.1	44.8	15.6	24.9	102.9	78.9	20.6	33.7
cash-flows.row.operating-cash-flow	1092.01	1092	1272	778.5	899.6	776.4	798.9	693.1	590.5	531.9	405.8	283.6	249.8	151.6	58.9	-15.9	-130.2	-81.1	-57.4	-52.2
cash-flows.row.capital-expenditure	-24.96	-24	-498.2	-45.5	-379.3	-182.3	-131.5	-114	-181.6	-36	-239	-11.3	-22.5	-5.8	-4.7	-6.1	-28.7	-3.1	-1.7	-1.4
cash-flows.row.free-cash-flow	1067.05	1068	773.8	733	520.4	594.1	667.4	579.1	409	496	166.8	272.3	227.3	145.8	54.1	-21.9	-159	-84.2	-59	-53.6

利润表行

Jazz Pharmaceuticals plc 的收入与上期相比变化了 0.048%。据报告, JAZZ 的毛利润为 2790.34。该公司的营业费用为 2131.06，与上年相比变化了 -18.243%. 折旧和摊销费用为 638.7，与上一会计期间相比变化了 0.066%. 营业费用报告为 2131.06，显示-18.243% 的同比变化。销售和营销费用为 0, 其中 0.000% 与上年相比发生了变化。基于近期数据的EBITDA为 0，同比增长0.287%. 营业收入为 659.28，与上年相比变化了0.287%. 净利润的变化率为 -2.937%。去年的净收入为414.83.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004
income-statement-row.row.total-revenue	3834.2	3834.2	3659.4	3094.2	2363.6	2161.8	1890.9	1618.7	1488	1324.8	1172.9	872.4	586	272.3	173.8	128.4	67.5	65.3	44.9	21.4	0
income-statement-row.row.cost-of-revenue	587.13	1043.9	540.5	440.8	148.9	127.9	121.5	110.2	105.4	102.5	117.4	102.1	78.4	13.9	13.6	9.6	13.9	8.9	7	4.3	0
income-statement-row.row.gross-profit	3247.07	2790.3	3118.9	2653.5	2214.7	2033.8	1769.4	1508.5	1382.6	1222.3	1055.5	770.3	507.6	258.3	160.2	118.8	53.6	56.4	37.9	17.1	0
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	849.66	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	1286.53	1476.9	599.2	525.8	259.6	354.8	201.5	152.1	102	98.2	126.6	79	65.4	7.4	7.8	7.7	12.8	46.8	9.6	5	-24.8
income-statement-row.row.operating-expenses	2587.77	2131.1	2606.6	2483.2	1449.2	1391.5	1111.6	894.7	767.2	682.5	617.9	430	309.7	130.5	102.4	102.9	194.2	195.2	115.9	74.3	-24.8
income-statement-row.row.cost-and-expenses	3174.9	3174.9	3147.1	2924	1598.1	1519.4	1233.2	1004.9	872.6	785.1	735.3	532.1	388.1	144.4	116	112.5	208.1	204.1	122.9	78.6	-24.8
income-statement-row.row.interest-income	65.2	65.1	11.5	1.8	99.7	20.5	0	0	0	0	0	0	0	0.1	0	0	1.8	5.9	0	0	0
income-statement-row.row.interest-expense	308.77	351.1	288.2	278.8	99.7	72.3	77.1	77.8	61.9	56.9	52.7	26.9	16.9	1.7	12.7	22.8	19.7	-13.6	0	0	0
income-statement-row.row.selling-and-marketing-expenses	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	-215.41	-361.4	-885.1	-283.1	-490.4	-78.1	-51.2	-95	-21	-46.9	-233.3	-5.4	-3.6	-1.2	-12.3	0	-25.8	-30	30.5	-22.2	0
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	1286.53	1476.9	599.2	525.8	259.6	354.8	201.5	152.1	102	98.2	126.6	79	65.4	7.4	7.8	7.7	12.8	46.8	9.6	5	-24.8
income-statement-row.row.total-operating-expenses	-215.41	-361.4	-885.1	-283.1	-490.4	-78.1	-51.2	-95	-21	-46.9	-233.3	-5.4	-3.6	-1.2	-12.3	0	-25.8	-30	30.5	-22.2	0
income-statement-row.row.interest-expense	308.77	351.1	288.2	278.8	99.7	72.3	77.1	77.8	61.9	56.9	52.7	26.9	16.9	1.7	12.7	22.8	19.7	-13.6	0	0	0
income-statement-row.row.depreciation-and-amortization	632.12	638.7	599.2	525.8	259.6	464.8	201.5	152.1	102	98.2	126.6	82.1	74.2	7.8	7.8	7.7	15	10.5	10.3	5.4	0
income-statement-row.row.ebitda-caps	1290.43	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	658.31	659.3	512.3	170.3	765.5	532.4	614.8	528.8	591.7	508.2	195.6	340.3	197.8	127.8	57.8	15.9	-170.4	-138.8	-78.1	-78.4	-24.8
income-statement-row.row.income-before-tax	297.93	297.9	-372.8	-112.8	275.1	454.3	529.5	441.1	532.4	435.9	151.6	307.9	177.4	125	32.8	-6.8	-184.3	-138.8	-47.6	-100.6	0
income-statement-row.row.income-tax-expense	-119.91	-119.9	-158.6	216.1	33.5	-73.2	80.2	-47.7	135.2	106.4	94.2	91.6	-83.8	2.8	25	22.8	43.7	0	-18.7	28	24.8
income-statement-row.row.net-income	414.83	414.8	-214.1	-329	238.6	523.4	447.1	487.8	396.8	329.5	58.4	216.3	288.6	125	32.8	-6.8	-184.3	-138.8	-59.4	-85.2	-24.8